Cargando…
Atrial Cardiomyopathy: Pathophysiology and Clinical Consequences
Around the world there are 33.5 million patients suffering from atrial fibrillation (AF) with an annual increase of 5 million cases. Most AF patients have an established form of an atrial cardiomyopathy. The concept of atrial cardiomyopathy was introduced in 2016. Thus, therapy of underlying disease...
Autores principales: | Goette, Andreas, Lendeckel, Uwe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533786/ https://www.ncbi.nlm.nih.gov/pubmed/34685585 http://dx.doi.org/10.3390/cells10102605 |
Ejemplares similares
-
Oxidative Stress and Microcirculatory Flow Abnormalities in the Ventricles during Atrial Fibrillation
por: Goette, Andreas, et al.
Publicado: (2012) -
Pathophysiological differences between atrial fibrillation subgoups: Is there a fibrillatory-induced atherosclerotic disease progression?
por: Goette, Andreas
Publicado: (2021) -
Anti-inflammatory effects of endothelin receptor blockade in left atrial tissue of spontaneously hypertensive rats
por: Bukowska, A., et al.
Publicado: (2022) -
Septic Cardiomyopathy: From Pathophysiology to the Clinical Setting
por: Carbone, Federico, et al.
Publicado: (2022) -
Pathophysiology of endotoxin tolerance: mechanisms and clinical consequences
por: López-Collazo, Eduardo, et al.
Publicado: (2013)